The Revenue Hijack: Inside the Industry Built to Bill Medicare for Care Your Practice Already Delivers

There is a scenario playing out in independent specialty practices across the country, and most physicians have no idea it is happening.

A company, one the practice has never contracted with, never heard of, and never authorized, is billing Medicare monthly for chronic care management and remote patient monitoring services on patients the specialist sees regularly.

The patient has CHF. Or COPD. Or poorly controlled hypertension. The specialist manages their medications, reviews their labs, coordinates their care. The clinical work is happening every day.

But the billing? Someone else captured it.

The Business Model Behind the Hijack

This is not a few bad actors. It is an industry, built deliberately, financed strategically, and scaled aggressively.

The model works like this: Companies hire enrollment specialists to contact Medicare beneficiaries directly. They identify patients with chronic conditions, the same patients who qualify for CCM and RPM billing codes, and pitch them "free" monitoring devices. A Bluetooth blood pressure cuff. A pulse oximeter. A scale.

The patient consents. The company ships the device. They assign a nurse, often managing 200 to 300 patients through monthly phone check-ins, and bill Medicare for "care coordination."

Some companies operate on a revenue-share model with the physician practice. Others bill under their own provider numbers and the practice never sees a dollar. In the worst cases documented by the HHS Office of Inspector General, companies enrolled patients without any prior medical relationship. One single operation billed RPM for over 30,000 patients it had never seen.

The scale: $536 million in Medicare RPM payments flowed through these operations in 2024, a 31% increase from the year prior. And 43% of enrolled patients didn't even receive all required service components.

The Consolidation Play

What makes this more than a billing issue is the investment infrastructure behind it. Private equity firms have been backing consolidation in this space, merging companies to create full-service "remote care" platforms that combine enrollment, device logistics, clinical staffing, and billing into a single operation.

The economics are compelling for the investor. Recurring monthly Medicare revenue. Low clinical overhead (one nurse per 200 to 300 patients). Patients who don't know to ask questions. Physicians who don't know the billing exists.

This is a machine. And it runs on physician inattention.

Why Specialists Are the Primary Target

The CCM and RPM conversation in healthcare has historically centered on primary care. Third-party companies don't make that mistake. They target specialty patients because the revenue per patient is higher (complex CCM pays $133/month vs. $62 for standard), the clinical complexity supports stacked billing codes, and, critically, most specialists have never billed a single CCM code. Zero resistance.

A cardiologist managing 200 Medicare patients with CHF, hypertension, and atrial fibrillation has a CCM/RPM revenue opportunity exceeding $150,000 to $350,000 annually. But most cardiologists I consult with have never captured a dollar of it. Not because they aren't doing the work, but because nobody showed them the documentation path.

CMS Acts, and the Vendors Fight Back

On July 14, 2026, CMS proposed banning outsourced RPM and RTM clinical services, effective January 1, 2027. Only clinical staff employed by the billing practice would be able to deliver these services.

The vendors' response was immediate: industry coalitions, lobbying campaigns, and public arguments that "physicians can't build these programs on their own." Their framing is concern for patient access. Their actual concern is protecting hundreds of millions in annual revenue.

But here is what matters for independent specialists: regardless of whether the ban survives the comment period, the underlying problem remains. If vendors stay, they keep your revenue. If vendors go, and you haven't built in-house capability, the revenue disappears entirely.

The only winning position is ownership.

What Independent Specialists Should Do Now

The window between now and January 2027 is the most important five months in Medicare revenue optimization for specialty practices.

For smaller practices (2 to 3 physicians, single location): Start with a focused assessment. Identify your conservative revenue recovery opportunity and get a 90-day roadmap. This doesn't require a major operational overhaul. It requires seeing the gap and building the documentation path to close it.

For mid-size and larger groups: A deeper diagnostic is warranted. Map your complete CCM/RPM opportunity. Evaluate documentation readiness. Identify third-party enrollment exposure. Build a prioritized action plan.

For practices ready for comprehensive analysis: A structured six-week advisory engagement, from stakeholder interviews through five-category gap analysis, revenue modeling, and a prioritized 90-day action roadmap, gives your team exactly what they need to build and own the program internally.

Better care coordination leads to better documentation. Better documentation leads to appropriate reimbursement. This is how Medicare was designed to work, and it's how independent specialists protect their practices from the revenue hijack.

We put together a guide that breaks down the full picture: the OIG findings, how the vendor business model works, what the proposed ban means, and the action plan for bringing CCM/RPM in-house.